105 related articles for article (PubMed ID: 14698185)
1. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model.
Nakayama K; Kawato H; Watanabe J; Ohtsuka M; Yoshida K; Yokomizo Y; Sakamoto A; Kuru N; Ohta T; Hoshino K; Yoshida K; Ishida H; Cho A; Palme MH; Zhang JZ; Lee VJ; Watkins WJ
Bioorg Med Chem Lett; 2004 Jan; 14(2):475-9. PubMed ID: 14698185
[TBL] [Abstract][Full Text] [Related]
2. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 4: Addressing the problem of poor stability due to photoisomerization of an acrylic acid moiety.
Nakayama K; Kuru N; Ohtsuka M; Yokomizo Y; Sakamoto A; Kawato H; Yoshida K; Ohta T; Hoshino K; Akimoto K; Itoh J; Ishida H; Cho A; Palme MH; Zhang JZ; Lee VJ; Watkins WJ
Bioorg Med Chem Lett; 2004 May; 14(10):2493-7. PubMed ID: 15109639
[TBL] [Abstract][Full Text] [Related]
3. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
[TBL] [Abstract][Full Text] [Related]
4. MexAB-OprM-specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: discovery and early strategies for lead optimization.
Nakayama K; Ishida Y; Ohtsuka M; Kawato H; Yoshida Ki; Yokomizo Y; Hosono S; Ohta T; Hoshino K; Ishida H; Yoshida K; Renau TE; Léger R; Zhang JZ; Lee VJ; Watkins WJ
Bioorg Med Chem Lett; 2003 Dec; 13(23):4201-4. PubMed ID: 14623001
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
[TBL] [Abstract][Full Text] [Related]
6. Functional interaction sites of OprM with MexAB in the Pseudomonas aeruginosa multidrug efflux pump.
Yoshihara E; Eda S; Kaitou S
FEMS Microbiol Lett; 2009 Oct; 299(2):200-4. PubMed ID: 19709308
[TBL] [Abstract][Full Text] [Related]
7. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: exploration of aromatic substituents.
Yoshida K; Nakayama K; Yokomizo Y; Ohtsuka M; Takemura M; Hoshino K; Kanda H; Namba K; Nitanai H; Zhang JZ; Lee VJ; Watkins WJ
Bioorg Med Chem; 2006 Dec; 14(24):8506-18. PubMed ID: 16979895
[TBL] [Abstract][Full Text] [Related]
8. Linkage of the efflux-pump expression level with substrate extrusion rate in the MexAB-OprM efflux pump of Pseudomonas aeruginosa.
Narita S; Eda S; Yoshihara E; Nakae T
Biochem Biophys Res Commun; 2003 Sep; 308(4):922-6. PubMed ID: 12927807
[TBL] [Abstract][Full Text] [Related]
9. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds.
Nakayama K; Ishida Y; Ohtsuka M; Kawato H; Yoshida K; Yokomizo Y; Ohta T; Hoshino K; Otani T; Kurosaka Y; Yoshida K; Ishida H; Lee VJ; Renau TE; Watkins WJ
Bioorg Med Chem Lett; 2003 Dec; 13(23):4205-8. PubMed ID: 14623002
[TBL] [Abstract][Full Text] [Related]
10. The mode of action of 2-(thiazol-2-ylthio)-1beta-methylcarbapenems against Pseudomonas aeruginosa: the impact of outer membrane permeability and the contribution of MexAB-OprM efflux system.
Eguchi K; Ueda Y; Kanazawa K; Sunagawa M; Gotoh N
J Antibiot (Tokyo); 2007 Feb; 60(2):129-35. PubMed ID: 17420563
[TBL] [Abstract][Full Text] [Related]
11. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: Carbon-substituted analogues at the C-2 position.
Yoshida K; Nakayama K; Kuru N; Kobayashi S; Ohtsuka M; Takemura M; Hoshino K; Kanda H; Zhang JZ; Lee VJ; Watkins WJ
Bioorg Med Chem; 2006 Mar; 14(6):1993-2004. PubMed ID: 16290941
[TBL] [Abstract][Full Text] [Related]
12. Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors.
Nehme D; Poole K
J Bacteriol; 2007 Sep; 189(17):6118-27. PubMed ID: 17586626
[TBL] [Abstract][Full Text] [Related]
13. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
[TBL] [Abstract][Full Text] [Related]
14. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
[TBL] [Abstract][Full Text] [Related]
15. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa.
Li XZ; Zhang L; Poole K
J Antimicrob Chemother; 2000 Apr; 45(4):433-6. PubMed ID: 10747818
[TBL] [Abstract][Full Text] [Related]
16. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
[TBL] [Abstract][Full Text] [Related]
17. Screening of Natural Products and Derivatives for the Identification of RND Efflux Pump Inhibitors.
Choudhury D; Talukdar AD; Chetia P; Bhattacharjee A; Choudhury MD
Comb Chem High Throughput Screen; 2016; 19(9):705-713. PubMed ID: 27450181
[TBL] [Abstract][Full Text] [Related]
18. Localization of the outer membrane subunit OprM of resistance-nodulation-cell division family multicomponent efflux pump in Pseudomonas aeruginosa.
Nakajima A; Sugimoto Y; Yoneyama H; Nakae T
J Biol Chem; 2000 Sep; 275(39):30064-8. PubMed ID: 10889211
[TBL] [Abstract][Full Text] [Related]
19. Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance.
Lee MD; Galazzo JL; Staley AL; Lee JC; Warren MS; Fuernkranz H; Chamberland S; Lomovskaya O; Miller GH
Farmaco; 2001; 56(1-2):81-5. PubMed ID: 11347972
[TBL] [Abstract][Full Text] [Related]
20. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate.
Yoshida K; Nakayama K; Ohtsuka M; Kuru N; Yokomizo Y; Sakamoto A; Takemura M; Hoshino K; Kanda H; Nitanai H; Namba K; Yoshida K; Imamura Y; Zhang JZ; Lee VJ; Watkins WJ
Bioorg Med Chem; 2007 Nov; 15(22):7087-97. PubMed ID: 17869116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
